All companies
Visit website
Lightsense Technology
OperatingLightsense Technology, Inc.
Technology · Founded 2014
Advanced optical pathogen detection to solve critical problems in pubic health
Post-money valuation ⓘ
$18.2M
As of Oct 2022 · from Lightsense Technology Preferred Stock 2 · pre-money + amount raised, not a traded price
Total raised
$924,776
Across 2 rounds since 2021
Latest share price
$8.57
Lightsense Technology Preferred Stock 2 offering price
Financials
FY2019–FY2023 · from SEC filings · hover any figure for its source$0
−$199K
2019
$26K
−$70K
2020
$26K
−$70K
2021
$89K
−$344K
2022
$70K
−$1.0M
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
FY2021
FY2022
FY2023
Income statement
Revenue
$0
$25,949
$25,949
$88,747
$69,500
Cost of goods sold
$0
$2,040
$2,040
$1,040
$4,596
Gross margin
—
92%
92%
99%
93%
Net income
-$199,495
-$69,896
-$69,896
-$343,533
-$1,005,797
Taxes paid
$0
$0
$0
$0
$0
Balance sheet
Cash
$71,367
$24,969
$24,969
$803,310
$474,821
Accounts receivable
$0
$16,549
$16,549
$0
$10,261
Total assets
$71,367
$50,850
$50,850
$910,771
$836,467
Short-term debt
$125,034
$0
$517,279
$51,411
$16,253
Long-term debt
$344,832
$514,131
$0
$569,382
$0
Total liabilities
$469,866
$514,131
$517,279
$620,793
$16,253
Other
Headcount
—
5
11
10
10
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$13.8M
post-money
$18.2M
post-money
Lightsense Technology Preferred Stock 1
Lightsense Technology Preferred Stock 2
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $180.4K / $2MInvestors 57Post-money $18.2M
Raised $744.4K / $1.1MPost-money $13.8M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 2 of 5 annual reports (FY2021–FY2025)
57 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001873409Share price $8.57
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.